BofA cuts Bath & Body Works stock price target on tariff concerns
BofA Securities has lowered its price target on Bath & Body Works Inc. (BBWI) stock from $30 to $25, while maintaining a Buy rating. The company reported better-than-expected third-quarter results and has maintained its full-year earnings per share outlook. Despite higher sales and share repurchases offsetting the impact of rising oil prices and gross margin pressure, BofA believes there is significant value in the stock.
The firm's fiscal 2026 earnings per share estimate remains unchanged, but the 2027 estimate has been reduced by 13% to $2.60 due to concerns over Canadian tariffs and input costs. The new $25 price target is ten times the firm's fiscal 2027 P/E estimate. BofA highlights that Bath & Body Works' management is addressing the brand's challenges.
InvestingPro analysis suggests the stock is currently undervalued. The analyst expects multiple expansion as the company improves sales and stabilizes margins. While Bath & Body Works reported strong third-quarter earnings exceeding Wall Street expectations, its shares saw a slight decline, likely due to concerns about store pressures and tariff-related cost challenges. Investors are monitoring the company's cautious holiday outlook.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.